Connection

Christopher Goodman to United States Food and Drug Administration

Back to Details
This is a "connection" page, showing publications Christopher Goodman has written about United States Food and Drug Administration.
Christopher Goodman
Connection Strength
0.315
United States Food and Drug Administration
  1. Race and Pharmacogenomics-Personalized Medicine or Misguided Practice? JAMA. 2021 Feb 16; 325(7):625-626.
    View in: PubMed
    Score: 0.177
  2. Gabapentin and Pregabalin for Pain - Is Increased Prescribing a Cause for Concern? N Engl J Med. 2017 Aug 03; 377(5):411-414.
    View in: PubMed
    Score: 0.138
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.